FIELD: chemistry.
SUBSTANCE: invention provides an agent for arresting undesirable vaccinal reactions and complications during primary vaccination with variolar vaccines, characterised by that it contains 7-[N'-(4-trifluoromethylbenzoyl)-hydrazine-carbonyl]-tricyclo[3.2.2.02,4]non-8-ene-6-carboxylic acid, and a method of using said agent in doses of 3.3-50 mg/kg body mass once a day on the day of vaccination and two days after vaccination, which does not reduce potency of the vaccine.
EFFECT: arrests undesirable vaccinal reactions and complications during primary vaccination with variolar vaccines.
2 cl, 5 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SMALLPOX VIRAL STRAIN GPA FOR STUDYING EFFICACY OF ANTIVIRAL PREPARATIONS in vivo AND ASSESSING REDUCTION ROUTINES UNDESIRED VACCINE REACTIONS ACCOMPANYING PRIMARY SMALLPOX VACCINATION | 2013 |
|
RU2542400C1 |
| MEDICATED PRODUCT FOR SMALLPOX VIRUS AND METHOD FOR PRODUCING AND USING IT | 2013 |
|
RU2543338C1 |
| LIVE ATTENUATED CULTURE VACCINE FOR PREVENTION OF SMALLPOX AND OTHER ORTHOPOXVIRUS INFECTIONS BASED ON SMALLPOX VACCINE VIRUS AND METHODS FOR ITS PREPARATION AND APPLICATION | 2022 |
|
RU2781070C1 |
| ORAL DOSAGE FORM OF THE PREPARATION IN CAPSULES FOR TREATING AND PREVENTING ORTHOPOXVIRUS-RELATED DISEASES | 2019 |
|
RU2716709C1 |
| INACTIVATED FETAL DRY TABLETED SMALLPOX VACCINE FOR ORAL ADMINISTRATION OF “THAOVIN” AND A METHOD FOR ITS PREPARATION | 2016 |
|
RU2651040C2 |
| METHOD FOR PRODUCTION OF PELLETIZED EMBRYONIC VARIOLAR LIVING VACCINE | 2005 |
|
RU2290949C1 |
| KIT OF TABLETTED ALIVE RECOMBINANT ORAL BIVACCINE AGAINST SMALLPOX AND HEPATITIS B AND METHOD FOR VACCINATION AT APPLYING THE KIT MENTIONED | 2005 |
|
RU2302259C2 |
| PREPARATION CONTAINING ANTIBODY ANTIVARIOLIC FROM WHEY OF BLOOD OF HORSES, SOLUTION FOR INTRAMUSCULAR INTRODUCTION | 2007 |
|
RU2342951C1 |
| 7-[N'-(4-TRIFLUOROMETHYLBENZOLYL)-HYDRAZINOCARBONYL]-TRICYCLO[3.2.2.0]NON-8-ENE-6-CARBOXYLIC ACID, HAVING ANTIVIRAL ACTIVITY | 2009 |
|
RU2412160C1 |
| METHOD OF ASSESSMENT OF ACTIVITY OF MEDICAL AND PREVENTIVE DRUGS AGAINST SMALLPOX VIRUS | 2014 |
|
RU2565812C1 |
